Is liver fibrosis a risk factor for gynecological cancers?

Abstract

A recent study by Crudele et al. reported on the association between surrogate indices of liver fibrosis and risk of gynecological cancers among dysmetabolic women. To put this study in context, notions regarding sex dimorphism in nonalcoholic fatty liver disease (NAFLD) are discussed. Additionally, meta-analytic reviews regarding the risk of extrahepatic cancers are reviewed. Next, I discuss the relationship of metabolic dysfunction-associated fatty liver disease (MAFLD) with extrahepatic cancers, notably including the breast and cancers of the female reproductive systems in humans. The pathomechanisms potentially accounting for this association include genetics, deregulated sex hormones, chronic subclinical inflammatory state, dysmetabolic milieu, oxidative stress, gut dysbiosis, environmental pollution, and altered immune surveillance.

Keywords

Breast cancer / uterine cancer / NAFLD / MAFLD

References

[1] Ludwig J,McGill DB.Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease.Mayo Clin Proc1980;55:434-8.

[2] Schaffner F.Nonalcoholic fatty liver disease.Prog Liver Dis1986;8:283-98.

[3] Lazarus JV,Anstee QM.NAFLD Consensus ConsortiumAdvancing the global public health agenda for NAFLD: a consensus statement.Nat Rev Gastroenterol Hepatol2022;19:60-78.

[4] Yki-Järvinen H.Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.Lancet Diabetes Endocrinol2014;2:901-10

[5] Lonardo A.Sexual dimorphism of NAFLD in Adults. Focus on clinical aspects and implications for practice and translational research.J Clin Med2020;9:1278 PMCID:PMC7288212

[6] Stachenfeld NS.Precision medicine requires understanding how both sex and gender influence health.Cell2022;185:1619-22

[7] Mantovani A,Beatrice G.Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.Gut2022;71:778-88

[8] Yi M,Feng X.Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analyses.Aliment Pharmacol Ther2022;56:1119-30

[9] Thomas JA,Dalais C,Thrift AP.Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: a systematic review and meta-analysis.Eur J Cancer2022;173:250-62

[10] Polyzos SA,Tsochatzis EA.Commentary: nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.Metabolism2020;113:154413

[11] Lonardo F.Metabolism and cancer-select topics.Metab Target Organ Damage2022;2:8

[12] Liu Z,Suo C.Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers.Metabolism2022;127:154955

[13] Wei S,Dong X.The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer.Front Endocrinol2023;14:985858 PMCID:PMC9987419

[14] Yuan X,Wu S.Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China.Hepatobiliary Surg Nutr2023;12:671-81. PMCID:PMC10598323

[15] Chung GE,Yoo JJ.Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: a population-based cohort study with 9.7 million Korean subjects.Cancer Commun2023;43:863-76 PMCID:PMC10397567

[16] Crudele L,Graziano G.AST/ALT-to-platelet ratio (AARPRI) predicts gynaecological cancers: a 8-years follow-up study in 653 women.Sci Rep2023;13:17793 PMCID:PMC10584967

[17] Allen AM,Mara KC,Therneau TM.The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - a longitudinal cohort study.J Hepatol2019;71:1229-36 PMCID:PMC6921701

[18] Lonardo A.The "obese liver" and gastrointestinal cancer risk.Transl Gastroenterol Hepatol2020;5:44 PMCID:PMC7063505

[19] Lonardo A.Concise review: breastfeeding, lactation, and NAFLD. An updated view of cross-generational disease transmission and prevention.Metab Target Organ Damage2023;3:16

[20] Lin X,Jiang T.Metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with cervical stromal involvement in endometrial cancer patients: a cross-sectional study in South China.Curr Oncol2023;30:3787-99 PMCID:PMC10136854

[21] Tai J,Chen WT.Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype.Cancer Sci2024;115:564-74 PMCID:PMC10859614

[22] Dolce A.Sex, nutrition, and NAFLD: relevance of environmental pollution.Nutrients2023;15:2335 PMCID:PMC10222590

[23] Yang L,Zhang CX.Influence of two anti-tumor drugs, pazopanib, and axitinib, on the development and thyroid-axis of zebrafish (Danio rerio) embryos/larvae.Front Endocrinol2023;14:1204678 PMCID:PMC10433177

[24] Wahlang B,Beier JI.Mechanisms of environmental contributions to fatty liver disease.Curr Environ Health Rep2019;6:80-94 PMCID:PMC6698418

[25] Sen P,Luukkonen PK.Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease.J Hepatol2022;76:283-93

[26] Rives C,Ellero-Simatos S.Oxidative stress in NAFLD: role of nutrients and food contaminants.Biomolecules2020;10:1702 PMCID:PMC7767499

[27] Liu W,Guo H.Single-cell transcriptome analysis of liver immune microenvironment changes induced by microplastics in mice with non-alcoholic fatty liver.Sci Total Environ2024;912:168308

[28] Ye Z,He P.Various ambient air pollutants, residential green spaces, fibrosis 4 scores, genetic susceptibility, and risk of severe liver disease.Ecotoxicol Environ Saf2023;263:115246

[29] Tovoli F,Mandrioli D.Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: a prospective pilot study.Dig Liver Dis2023;Online ahead of print:S1590-8658(23)01097-6

[30] Wen Q,Yu Y.Self-reported primary cooking fuels use and risk of chronic digestive diseases: a prospective cohort study of 0.5 million Chinese adults.Environ Health Perspect2023;131:47002 PMCID:PMC10069757

[31] Cazzolla Gatti R,Monaco A,Amoroso N.The spatial association between environmental pollution and long-term cancer mortality in Italy.Sci Total Environ2023;855:158439

[32] Eom SY,Bae S.Health effects of environmental pollution in population living near industrial complex areas in Korea.Environ Health Toxicol2018;33:e2018004 PMCID:PMC5903037

[33] Korsh J,Aliano K.Polycyclic aromatic hydrocarbons and breast cancer: a review of the literature.Breast Care2015;10:316-8 PMCID:PMC4677716

[34] Park JH,Kim OH.Polypropylene microplastics promote metastatic features in human breast cancer.Sci Rep2023;13:6252 PMCID:PMC10108816

[35] Sulaiman SA,Adrus MNH.Genetic polymorphisms and diversity in nonalcoholic fatty liver disease (NAFLD): a mini review.Biomedicines2022;11:106 PMCID:PMC9855725

[36] George ES,Kiss N.The evidence surrounding non-alcoholic fatty liver disease in individuals with cancer: a systematic literature review.Curr Oncol2022;30:48-74 PMCID:PMC9857873

[37] Ballestri S,Di Girolamo M,Capitelli M.Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality.Metab Target Organ Damage2023;3:1.